More questions over label changes

Pharmacy groups have welcomed proposals to alter the advisory labels of a number of medicines, although questions have been raised over new indications for lidocaine The proposals are part of a series of advisory label changes by the Therapeutic Goods Administration (TGA) for Required Advisory Statements for Medicine Labels, and included a number of different